On June 25, 2020, fenfluramine (Fintepla) was approved for the treatment of seizures associated with Dravet syndrome in patients 2 years and older.
Youssef Bessada, PharmD
Advertisement
Articles by Youssef Bessada, PharmD
Advertisement
Latest Updated Articles
Fenfluramine for the Treatment of Seizures Associated With Dravet SyndromePublished: October 6th 2020 | Updated:
Advertisement
Advertisement
Trending on Drug Topics
1
Oral Semaglutide Show Promise as New Benchmark for Diabetes Care, Cardiovascular Protection
2
Opioid Overdose Deaths Fall by 34% in 2025 | ASHP Midyear 2025
3
Limited Clinical Data Impact Cannabis Integration Into Standard Care | ASHP Midyear 2025
4
What TrumpRx Means for Independent Pharmacies and Their Patients
5
